Hepatitis D clinical trials

Explore recruiting hepatitis d clinical trials.

Recruiting hepatitis d studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Hepatitis D trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Global, Randomized, Open-label, Multicenter Phase 3 Trial Evaluating BJT-778 vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2)

Austria, Italy, Czechia, Romania, Sweden, Spain +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A study to determine the safety and effect of antibodies against hepatitis D (the SAMBA-D study)

Germany, Denmark

Human Pharmacology (Phase I)- Other EU CTIS Study details

A Phase 2b/3, Open-Label, Multicenter Trial Evaluating the Efficacy and Safety of Switching to Brelovitug for the Treatment of Chronic Hepatitis Delta Infection in Participants Receiving Bulevirtide (AZURE-3)

Czechia, Austria, Spain, Romania, Germany, Italy +1 more

Phase II and Phase III (Integrated) EU CTIS Study details

A Randomized, Open-label, Multicenter, Phase 3 Trial Evaluating Brelovitug vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection (AZURE-4)

Belgium, Hungary, Bulgaria

Therapeutic confirmatory (Phase III) EU CTIS Study details

Observational Study to Evaluate Efficacy, Safety and Biomarkers of Bulevirtide Treatment in Patients with Chronic hepatitis D

Sweden

Phase III and phase IV (Integrated) EU CTIS Study details

A Global, Randomized, Open-label, Multicenter, Phase 2b/3 Trial Evaluating BJT-778 vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection (AZURE-1)

Bulgaria

Phase II and Phase III (Integrated) EU CTIS Study details

Hepatitis D trials by city

Hepatitis D in Toronto Hepatitis D in Vancouver Hepatitis D in Montreal Hepatitis D in Calgary Hepatitis D in Edmonton Hepatitis D in Ottawa Hepatitis D in Winnipeg Hepatitis D in Quebec City Hepatitis D in Hamilton Hepatitis D in Kitchener Hepatitis D in London Hepatitis D in Halifax Hepatitis D in New York Hepatitis D in Los Angeles Hepatitis D in Chicago Hepatitis D in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease